Legal Representation
Attorney
Amanda M. Prose
USPTO Deadlines
Application History
20 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 25, 2025 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | Loading... |
| Jun 25, 2025 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | Loading... |
| Jun 25, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jun 25, 2025 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Jun 25, 2025 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Jun 25, 2025 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | Loading... |
| Mar 25, 2025 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Mar 25, 2025 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Mar 25, 2025 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Feb 19, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Feb 19, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Feb 19, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Nov 4, 2024 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | Loading... |
| Nov 4, 2024 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | Loading... |
| Aug 20, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Aug 20, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Aug 20, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Aug 19, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| May 23, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jan 23, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceuticals, namely, pharmaceuticals for the treatment of cancers and tumors in humans; medical preparations, namely, immunotherapeutic agents for the treatment and prevention of cancers and tumors in humans; immunotherapeutic agents for the treatment and prevention of cancers and tumours in humans.
Class 042
Scientific and technological services and research and design relating thereto in the fields of genetics, immunotherapy, oncology and cancer or tumor therapy; industrial research in the fields of genetics, immunotherapy, oncology and cancer therapy; medical and pharmacological research services; medical research services; research and development of medicines; research and development of immunotherapeutic agents and medicines, oncology and cancer therapeutic agents and medicines.
Classification
International Classes
005
042